Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MoonLake Immunotherapeutics | Chief Financial Officer | Class A ordinary shares, par value $0.0001 per share | 521K | $30.4M | $58.34 | Dec 20, 2023 | Direct |
MoonLake Immunotherapeutics | Chief Financial Officer | Class C ordinary shares, par value $0.0001 per share | 294K | Oct 1, 2023 | Direct | ||
MoonLake Immunotherapeutics | Chief Financial Officer | Common shares, par value CHF 0.10 per share, of MoonLake AG | 8.75K | Oct 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MLTX | MoonLake Immunotherapeutics | Dec 19, 2023 | 2 | -$5.92M | 4 | Dec 21, 2023 | Chief Financial Officer |
MLTX | MoonLake Immunotherapeutics | Oct 1, 2023 | 3 | $0 | 4 | Oct 3, 2023 | Chief Financial Officer |
MLTX | MoonLake Immunotherapeutics | Apr 5, 2023 | 6 | $0 | 4 | Apr 7, 2023 | Chief Financial Officer |
MLTX | MoonLake Immunotherapeutics | Apr 5, 2022 | 0 | $0 | 3 | Apr 15, 2022 | Chief Financial Officer |